Ophthalmic Devices Market (By Product: Vision Care Products, Surgical Devices, Vitreoretinal Surgical Devices, Refractive Surgical Devices, Glaucoma Surgical Devices, Ophthalmic Microscopes, Ophthalmic Surgical Accessories, Diagnostic and Monitoring Devices; By End User: Hospitals & Eye Clinics, Academic & Research Laboratories, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032


The global ophthalmic devices market size was estimated at USD 44.03 billion in 2023 and it is expected to hit around USD 67.15 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2032.

Ophthalmic Devices Market Size 2023 To 2032

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaway:

  • North America captured more than 43% of the revenue share in 2022.
  • By Product, the optical coherence tomography scanners segment contributes to most of the market.
  • By Application, the cataract segment is recording for most of the market.
  • By end use, the hospitals & eye clinics segment generated more than 79% of the revenue share in 2022.

Ophthalmic Devices Market in the U.S. 2023 To 2032

The U.S. ophthalmic devices market size was valued at USD 13.28 billion in 2023 and is expected to reach USD 20.60 billion by 2032, growing at a CAGR of 5% from 2023 to 2032.

U.S. Ophthalmic Devices Market Size 2023 to 2032

North America had the largest market share till the last year as an increasing geriatric population and prevailing eye conditions in the North American region the market for ophthalmic devices is expected you grow during the forecast period. Unhealthy lifestyles are resulting in diabetic retinopathy and other stress related complaints these are the reasons why the industry for ophthalmic devices is growing. The demand for ophthalmic devices is expected to grow in the North American region due to the various reimbursement models incorporated by the insurance providers and the regulatory framework aimed at the patient safety.

The Asia Pacific market is also expected to have a good growth during the forecast. As an increasing demand for eye care and health care infrastructure is improving in this region prevailing eye disorders like glaucoma and the awareness of patient towards the surgeries related to it are helping in the growth of the market. The availability and the increased awareness regarding the advanced corrective vision treatments in the developing nations shall be a major driving factor during the forecast.

Ophthalmic Devices Market Share, By Region, 2022 (%)

Market Overview

Increasing demand for quality eye care and increasing demand for surgeries for vision disorders will help in the growth of the global ophthalmic devices market. Ophthalmic devices are devices that are used in improving vision disorders or which can help in aiding vision. Various market players are focusing on strengthening their research and development teams for the development of devices in the treatment of vision errors developments in this field would provide a huge opportunity to capture a large cost customer base and accelerate the growth of the ophthalmic devices market.

The pandemic had a negative impact on the ophthalmic devices market due to an increase in the dry eye diseases the eye drops were sold mold during the pandemic but major surgeries or sales of contact lenses had come down drastically.

Growth Factors

Due to an increase in cataract surgeries and implants the surgical segment is expected to grow and increasing demand for eye surgeries is expected to help in the growth of the market. As there is an increase in the demand for contact lenses and innovative equipments these devices shall lead the market. Micro invasive glaucoma surgical implants are the fastest growing market treatment. Due to many disorders related to the eyes like the diabetic retinopathy, cataracts, age related degeneration and all the other prevailing ophthalmic disorders shall lead to a growth of the market.

Rapid increase in the eye disease is due to many lifestyle changes is expected to fuel the demand for surgical and vision care devices increased per capita income and high disposable income, favorable reimbursement policies, easily available ophthalmic procedures are increasing the surgical procedures and therefore the demand for ophthalmic devices market is growing.

Increased screen time during the lockdowns in pandemic are associated with the various eye disorders and it shall drive the demand for eye examinations. Increased initiatives by the government to create an awareness regarding the visual disorders or impairments shall further drive the market.

Ophthalmic Devices Market Scope

Report Coverage Details
Market Size in 2023 USD 44.03 Billion
Market Size by 2032 USD 67.15 Billion
Growth Rate from 2023 to 2032 CAGR of 4.8%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Product, End User, and Geography
Companies Mentioned Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., Ziemer Ophthalmic Systems AG, Hoya Corporation, HAAG-Streit Holding AG, Johnson & Johnson and Others

 
Product Insights

Ophthalmic devices are segmented into vision care and surgical devices. The vision care segment has the largest market share and is expected to grow well in the forthcoming years as many patients with the eye disorders using eyeglasses are shifting to contact lenses. Advances in the contact lenses are anticipated to create a more demand for the product in the market. About 45 million people in US use contact lenses and this shall increase in the coming years leading to a growth in the market. An increase in intraocular lens and the number of cataract and retinal surgeries the ophthalmic devices market shall see a growth in the forecast.

The cataract segment dominated the market in the recent years and it is expected to see a significant growth during the forecast. Due to higher adoption of these devices and increasing cataract surgeries is driving the market. The leading cause of blindness is scattered has a demand for cataract surgeries. 51% of blindness cases across the world are due to cataract the other segment that will show fast growth during the forecast period is the refractor disorder segment. About 2 billion people have near or far-distance vision impairment in order to treat all of these disorders which are related to the eyes and correct the refractive errors ophthalmic devices has a great demand across the globe. As an increasing population major market players are focusing on meeting the requirements of the rising patient demands. Major players are also introducing advanced ophthalmic diagnosis and treatment devices across the globe.

End User Insights

On the basis of the end user, the hospital and eye clinic segment had the largest market share in the ophthalmic devices market and it is expected to grow during the forecast period. There is an increasing adoption of ophthalmic devices in the hospitals which provide effective and low-cost treatment. The adoption of ophthalmic devices in the clinic is also growing as an increasing number of mergers and acquisitions in major and minor ophthalmic clinics and hospitals is there. An increasing number of mergers and acquisitions in various ophthalmic clinics and hospital the demand for ophthalmic devices is expected to grow during the forecast.

Ophthalmic Devices Market Share, By End User, 2022 (%)

Many eye clinics are coming up with separate diagnostic departments which help in boosting the market of ophthalmic devices. The cost-effective eye treatment across the developing and the developed nations is expected to drive the market growth during the forecast period. The demand for ophthalmic devices is expected to grow in the academic and research laboratories segment.

Ophthalmic Devices Market Players

  • Novartis AG
  • Carl Zeiss Meditec AG
  • Essilor International S.A.
  • Nidek Co., Ltd.
  • Topcon Corporation
  • Valeant Pharmaceuticals International, Inc.
  • Ziemer Ophthalmic Systems AG
  • Hoya Corporation
  • HAAG-Streit Holding AG
  • Johnson & Johnson

Key Market Developments:

  • Bausch + Lomb Launched preloaded delivery system and pure refractive optics (PRO) technology in May 2020 which is the first of its kind, named EDOF IOL LuxSmart and a monofocal IOL LuxGood
  • VRmagic Holding AG (Germany) was acquired by Haag-Streit Group (Switzerland) in April 2020 to strengthen Haag-Streit’s leading position in the ophthalmology market
  • In order to raise awareness about AMD through social media pages to share information about AMD with the public, Bausch + Lomb (Canada)collaborated with Prevent Blindness (US) in February 2020,
  • Johnson & Johnson Vision Care (US) launched ACUVUE VITA in September 2019, which are the contact lenses for astigmatism in the US.
  • In February 2019, Carl Zeiss Meditec (Germany) opened a training center in Pune, India in collaboration with the Poona Blind Men Association. Carl Zeiss Meditec (Germany) had collaborated with Christoffel Mission for the Blind (CBM) (Germany).

Segments Covered in the Report

By Product

  • Vision Care Products
    • Spectacles
    • Contact lenses
      • Soft contact lenses
      • Rigid gas permeable lenses
      • Hybrid contact lenses
  • Surgical devices
    • Cataract surgical devices
      • Intraocular lenses
      • Ophthalmic Viscoelastic devices
      • Phacoemulsification devices
      • Cataract surgical lasers
      • IOL Injectors
  • Vitreoretinal surgical devices
    • Vitrectomy machines
    • Vitreoretinal packs
    • Photocoagulation lasers
    • Illumination devices
    • Vitrectomy probes
  • Refractive surgical devices
    • Femtosecond lasers
    • Excimer lasers
    • Others
  • Glaucoma surgical devices
    • Glaucoma drainage devices
    • Microinvasive glaucoma surgery devices
    • Glaucoma laser systems
  • Ophthalmic microscopes
  • Ophthalmic surgical accessories
    • Surgical instruments & kits
    • Ophthalmic forceps
    • Ophthalmic spatulas
    • Ophthalmic tips & handles
    • Ophthalmic scissors
    • Macular lenses
    • Ophthalmic cannulas
    • Others
  • Diagnostic and monitoring devices
    • Optical Coherence Tomography Scanners
    • Fundus Cameras
    • Perimeters/Visual Field Analyzers
    • Autorefractors & Keratometers
    • Ophthalmic Ultrasound Imaging Systems
      • A-scan ultrasound imaging systems
      • B-scan ultrasound imaging systems
      • Ultrasound microscopes
      • Pachymeters
    • Tonometers
    • Slit Lamps
    • Phoropters
    • Wavefront Abberometers
    • Optical Biometry Systems
    • Ophthalmoscopes
    • Lensmeters
    • Corneal Topography Systems
    • Chart Projectors
    • Specular Microscopes
    • Retinoscopes

By End User

  • Hospitals & Eye Clinics
  • Academic & Research Laboratories
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

What is the current size of ophthalmic devices market?
The global ophthalmic devices market was accounted at USD 44.03 billion in 2023 and is poised to reach around USD 67.15 billion by 2032.
What will be the CAGR of global ophthalmic devices market?
The global ophthalmic devices market is anticipated to grow at a CAGR of 4.8% from 2023 to 2032.
Who are the prominent players operating in the ophthalmic devices market?
The key players operating in the ophthalmic devices market are Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., Ziemer Ophthalmic Systems AG, Hoya Corporation, HAAG-Streit Holding AG, Johnson & Johnson and Others.
Which are the driving factors of the ophthalmic devices market?
Increasing demand for contact lenses and innovative equipments and increasing initiatives by the government are driving the the ophthalmic devices market.
Which region will lead the global ophthalmic devices market?
North America region will lead the global ophthalmic devices market.

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample